Dry eye disease - ciclosporin (after artificial tears) [ID665]: committee papers

Table of contents

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer - Santen GmBH

03 - NICE request to the manufacturer for clarification on their submission

04 - NICE request for further clarification, additional question from the ERG

05 - Manufacturer clarification response

06 - Consultee submission - Royal College of Nursing

07 - Clinical expert personal perspective - Boboridis

08 - Clinical expert personal perspective - Figueiredo

09 - Evidence Review Group report prepared by Liverpool Reviews and Implementation group (LRiG)

10 - Manufacturer factual accuracy check of Evidence Review Group report

11 - Evidence Review Group erratum prepared by Liverpool Reviews and Implementation group (LRiG)

This page was last updated: 22 June 2015